Prenatal and women's health supplements: controls that reach the label
Write specifications for every declared nutrient, identity-test each dietary ingredient component, and add the iron warning where 101.17(e) applies.

In Short
- ID-test each dietary ingredient.
- Iron warning: solid oral iron source.
- Label tied to formula version.
The Dietary Supplement Operations Guide
What the label says. What the batch proves.
- The rules and who decides
- Specification to finished batch
- Test, review, investigate
We ask for your name and email so we can handle this request. The full guide then opens on this site, ready to translate, print or save. Privacy policy. Practical orientation, not legal advice; your quality unit decides which rules apply.
UltimateFree guide
The Dietary Supplement Operations Guide
What the label says. What the batch proves.

Prenatal and women's health supplements are dietary supplements, so in the United States they follow 21 CFR Part 111 manufacturing rules and Part 101 labelling rules like any other. What sets them apart is who takes them, which makes identity, strength, contaminant limits and warnings especially important. This review opened the current eCFR text of 21 CFR 111.70, 111.75 and 111.123 and 21 CFR 101.17(e) and 101.36; claim substantiation and pregnancy-specific safety evidence were not reviewed. This guide summarises the sources named here; it is orientation, not legal advice. Sources checked 5 Oct 2026.
Specifications Come First
Section 111.70 requires specifications at every point, step or stage where control is needed to ensure quality. For each component you need an identity specification, specifications needed to meet the finished product's purity, strength and composition, and limits on contamination that may adulterate the batch.
Worked Example: Specifications for Formula PN-12
| Item | Specification | Evidence |
|---|---|---|
| Folate (as declared form) | Identity and strength | Test per lot |
| Iron (ferrous fumarate) | Identity and strength | Test per lot |
| Finished tablets | Strength of declared nutrients; contaminant limits | Batch testing plan |
- Folate (as declared form)
- Specification
- Identity and strength
- Evidence
- Test per lot
- Iron (ferrous fumarate)
- Specification
- Identity and strength
- Evidence
- Test per lot
- Finished tablets
- Specification
- Strength of declared nutrients; contaminant limits
- Evidence
- Batch testing plan
More on specifications Come First
Finished product specifications cover identity, purity, strength, composition and contaminant limits. For a prenatal formula, write strength limits for each nutrient you declare and contaminant limits suited to the people who will take it.
Identity Testing of Dietary Ingredients
Section 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient before use, unless FDA grants an exemption under a petition described in 111.75(a)(1)(ii). Components that are not dietary ingredients follow 111.75(a)(2), which allows reliance on a supplier's certificate of analysis once you have qualified that supplier as the section describes.
More on identity Testing of Dietary Ingredients
Folate, iron, iodine and botanical ingredients each need a method suited to the form you buy. Record which test was used and who accepted the lot.
Release is blocked when results fail
Under section 111.123(b) quality control personnel must not approve and release for distribution any batch in which a component does not meet its identity specification, or any batch that does not meet all product specifications set under section 111.70(e). Section 111.123(a) also gives them material review and disposition decisions.
More on release is blocked when results fail
Make these decisions visible in the record with the person, date and reason, and keep rejected material physically and electronically separated.
The Iron Warning
Section 101.17(e) applies to dietary supplements in solid oral dosage form, such as tablets or capsules, that contain iron or iron salts for use as an iron source. For those products the label must carry the accidental-overdose warning set out in the regulation, word for word, and it must appear prominently and conspicuously on the information panel of the immediate container label, with separate rules for unit-dose packaging.
Iron warning check (101.17(e))
More on the Iron Warning
Decide for each product whether it is in scope, record that decision, and check in-scope label versions against the regulation's text.
Supplement Facts and Label Control
Section 101.36 sets the Supplement Facts format: serving size, servings per container, each dietary ingredient with its amount and, where established, percent Daily Value, with separate rules for groups such as pregnant and lactating women. Keep the label artwork as a controlled document tied to the formula version, and require quality and regulatory approval before printing.
More on supplement Facts and Label Control
When a formula changes, the label change should move through the same change record.
Questions
Which components need an identity test?
Each component that is a dietary ingredient needs at least one appropriate identity test or examination before use under 111.75(a)(1)(i), unless FDA grants a petition exemption under 111.75(a)(1)(ii).
Which prenatal products need the iron warning?
Dietary supplements in solid oral dosage form containing iron or iron salts for use as an iron source, under 21 CFR 101.17(e). Other forms are outside that paragraph.
Can we rely on a supplier's certificate of analysis?
For components that are not dietary ingredients, yes, after you qualify the supplier as section 111.75(a)(2) describes. Components that are dietary ingredients require the identity test under 111.75(a)(1)(i), unless FDA grants the petition exemption described in 111.75(a)(1)(ii).
Does this guide cover pregnancy safety claims?
No. Claim substantiation and safety evidence for pregnancy were not reviewed; your regulatory and medical advisers decide those.
Practical orientation, not legal advice. Rules differ by jurisdiction; your quality and compliance team decides what applies.
Keep reading
21 CFR 111 Readiness: Identity, Master and Batch Records
Africa Supplement Regulation: SAHPRA, NAFDAC & Kenya PPB
Supplement Allergen Control: Validated Cleaning and Labelling
ASEAN Supplement Rules: BPOM, Thai FDA, Vietnam and PH FDA
Canada Natural Health Products Regulations: Licences, GMP, Labels and Reporting
Canada NNHPD: NPN, Monographs, Site Licence and Claims